Search
for
Sort by
Research 151–180 of 1000+
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Update: baricitinib for alopecia areata
- Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Alopecia in general medicine
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
- Real-world evidence in alopecia areata treatment: A narrative review
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Alopecia areata: current concepts
- Alopecia areata – Current understanding and management
- Alopecia areata following COVID-19 vaccine: a systematic review
- When hair dig into the brain, JAKi , may help!
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Emerging treatments in alopecia